Scripted consultations for HPV test positive women: a pilot trial (grant writing proposal)

Lead researcher
Clare Wilkinson, Diana Pasterfield, North Wales Clinical Sschool, Bangor University

To determine the feasibility of a randomised controlled trial of evidence-based scripted consultations, for HPV positive women with abnormal smear tests, designed to reduce anxiety, inform uptake, and improve disease control.

Cervical cancer prevention is rapidly evolving, as high risk types 16 and 18 human papillomavirus (HPV) are known to cause about 70% of invasive cervical cancer.  The HPV vaccination programme began in 2008 in the UK for 12- to 13-year-old girls, with a catch-up campaign for girls to 18 years.  A new protocol for HPV triage and test of cure was launched in April 2011 in the NHS cervical screening programme. 

The combined vaccination programme and cervical screening programme will lead to changes in the epidemiology of cervical cancer, and a series of complex, new communication challenges for health care providers. The triad of informed choice, minimized anxiety and disease control remain key policy features of cervical cancer prevention.  The HPV core messages study comprising systematic reviewing, qualitative work and public and health provider surveys was to develop evidence-based messages for use alongside these new technologies.

Study design summary
Develop the team
Proposal development
Pilot RCT

Total awarded